The life sciences BPO market comprises outsourcing services provided to pharmaceutical, biotechnology, medical device companies and others in the healthcare industry. It helps life sciences companies to focus on core activities of drug discovery, product development and commercialization. Services like regulatory affairs management, clinical data management, medical writing and publishing, pharmacovigilance, medical monitoring and other clinical trial related services are outsourced to specialized BPO players. Factors such as cost optimization, access to advanced infrastructure and expertise, complex regulatory frameworks and need to streamline operations has increased outsourcing in the life sciences sector
Global life sciences BPO market growth is driven by rising need for cost-optimization among life sciences companies coupled with benefits of access to advanced infrastructure and expertise delivered by BPO service providers. Moreover, regulatory frameworks for drug development and approval have become highly complex over the years, thus, necessitating outsourcing of non-core functionalities. Changing dynamics of the healthcare industry including shift towards value-based care has also prompted life sciences players to streamline their operations through strategic outsourcing. However, factors such as data security concerns, loss of control over critical functions and operational challenges associated with vendor management can hamper the market growth. Growing healthcare expenditure in developing regions, development of biosimilars & genomic drugs and integration of AI/blockchain to enhance BPO services can offer market growth opportunities.
- This report provides in-depth analysis of the global life sciences BPO market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global life sciences BPO market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Cognizant, Accenture, Genpact, EXL services, and Catalent.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global life sciences BPO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global life sciences BPO market.
- Pharmaceutical outsourcing
- Contract manufacturing market
- API
- Finished dose form
- Packaging
- Contract research organizations
- Drug discovery
- Preclinical studies
- Clinical trial studies
- Regulatory services
- Pharmacovigilance
- Medical devices outsourcing
- Contract manufacturing market
- Electronic manufacturing services
- Finished goods
- Raw materials/components
- Contract research organizations
- Regulatory consulting services
- Product design and development services
- Product testing services
- Product implementation services
- Product upgrade services
- Product maintenance services
- Contract sales & market outsourcing
- Others
-
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations Medical Device Companies
- Academic Institutes & Government Organizations
-
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
-
- Accenture, Plc
- Boehringer Ingelheim GmbH
- Cognizant Technology Solutions
- Infosys
- Genpact Limited
- ProMab Biotechnologies, Inc.
- Charles River Laboratories International, Inc.
- Catalent, Inc.
- Covance, Inc.
- Fareva
- ICON, Plc
- DSM
- Health Decisions, Inc.
- IQVIA
- Laboratory Corporation of America Holdings
- Syneos Health, Inc.
- Parexel International Corporation
- PRA Health Sciences
